Bullboard - Stock Discussion Forum Mydecine Innovations Group Inc MYCOF

Primary Symbol: C.MYCO

Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning... see more

Add To Watchlist

CSE:MYCO - Post Discussion

Mydecine Innovations Group Inc > The Hault was just about the same news that was released

View:

Post by MrVerbatim9800 on Jan 14, 2021 10:54am

The Hault was just about the same news that was released

This morning...

Mydecine Innovations Group Announces C$10 Million Bought Deal Offering of Units

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

DENVER, Jan. 14, 2021 /CNW/ – Mydecine Innovations Group™ (CSE:MYCO)(OTC:MYCOF)(FSE: 0NFA) (”Mydecine” or the ”Company”), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp. (“Canaccord Genuity” or the “Underwriter”), pursuant to which Canaccord Genuity has agreed to purchase, on a bought deal basis pursuant to the filing of a short form prospectus, an aggregate ...

Read The Full Article On MicroSmallCap.com

Get early insight on hidden secret gems on MicroSmallCap . Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here .

All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer .

For further details see:

Mydecine Innovations Group Announces C$10 Million Bought Deal Offering of Units

Source: MicroSmallCap (Jan 14, 2021 10:40:44 EST)

News by QuoteMedia
www.quotemedia.com

204